Advertisement
Novara — A Smarter Way to Access Global Markets
LIVE DESK·Global markets desk

Business

AB Foods Shares Plunge 9% on Weak Primark Guidance
EarningsArticle

AB Foods Shares Plunge 9% on Weak Primark Guidance

Associated British Foods lowered fourth-quarter Primark sales expectations and issued a wider sugar loss outlook for 2027, driving shares down more than 9% in early London trading.

Priya Anand · 20 Sept 2026
FINMA warns of AI-fuelled cyberattacks hitting Swiss financial sector
CompaniesArticle

FINMA warns of AI-fuelled cyberattacks hitting Swiss financial sector

Switzerland's financial regulator says attacks on its sector surged 33%, with bad actors increasingly using generative-AI tools from firms such as OpenAI and Anthropic.

Helena Vásquez · 20 Sept 2026
Dream Finders Homes Stock Hits 52-Week Low Amid Beazer Acquisition
M&AArticle

Dream Finders Homes Stock Hits 52-Week Low Amid Beazer Acquisition

Dream Finders Homes shares fell to $12.17, a 59% annual decline, as it moves forward with its $2.2 billion all-cash acquisition of Beazer Homes USA.

Lucas Ferreira · 20 Sept 2026
UBS Posts $2.8B Q2 Profit, Eyes $3B Buyback Despite Swiss Capital Rules Tension
EarningsArticle

UBS Posts $2.8B Q2 Profit, Eyes $3B Buyback Despite Swiss Capital Rules Tension

Switzerland's largest bank reported a 17% jump in quarterly profit driven by wealth-management inflows, even as regulatory debates with Bern cast uncertainty over its capital-return plans.

Priya Anand · 20 Sept 2026
Lombard Odier: Young donors demand measurable impact and innovation
CompaniesArticle

Lombard Odier: Young donors demand measurable impact and innovation

A survey of 260 high-net-worth individuals across four markets reveals generational divides in philanthropic priorities and a surging demand for banks to integrate giving into wealth strategies.

Helena Vásquez · 20 Sept 2026
GSK Reports Strong Trial Data for Lung Cancer Drug Jideytro
CompaniesArticle

GSK Reports Strong Trial Data for Lung Cancer Drug Jideytro

GSK's ARROS-1 trial showed a 94% response rate and 100% intracranial response in treatment-naïve ROS1-positive lung cancer patients, boosting outlook for a supplemental FDA filing this year.

Helena Vásquez · 20 Sept 2026
Hardide Lands $1.9M Order for Energy Sector Components
CompaniesArticle

Hardide Lands $1.9M Order for Energy Sector Components

Hardide secured a $1.9 million production order from a North American energy customer for second-generation tungsten carbide-coated components, to be delivered starting October 2026.

Helena Vásquez · 20 Sept 2026
Arcus Biosciences sees $4B+ frontline opportunity for HIF-2α inhibitor casdatifan
CompaniesArticle

Arcus Biosciences sees $4B+ frontline opportunity for HIF-2α inhibitor casdatifan

Arcus Biosciences presented late-line and combination clinical data for casdatifan at Cantor's healthcare conference, projecting up to $6 billion in combined commercial opportunity across metastatic kidney cancer.

Helena Vásquez · 20 Sept 2026
Incyte outlines $3B–$4B revenue floor, pipeline-driven growth through 2035
CompaniesArticle

Incyte outlines $3B–$4B revenue floor, pipeline-driven growth through 2035

CEO Bill Meury said Incyte aims to reach a $3 billion–$4 billion core-business revenue floor within 12–18 months, with five key assets representing roughly 80% of post-Jakafi recovery.

Helena Vásquez · 20 Sept 2026
Athens International Airport Reports 4.5% Passenger Growth in H1 2026, Raises Full-Year Profit Guidance
EarningsArticle

Athens International Airport Reports 4.5% Passenger Growth in H1 2026, Raises Full-Year Profit Guidance

The airport posted record passenger traffic and raised its full‑year profit outlook despite a slight dip in revenue, while detailing a revised expansion plan and a successful bond issuance.

Priya Anand · 20 Sept 2026
Imperial Petroleum Posts Record Q2 Revenue, Beats EPS Estimates
EarningsArticle

Imperial Petroleum Posts Record Q2 Revenue, Beats EPS Estimates

Greek shipping firm reports $87.1M in quarterly revenue, up 140% year-over-year, as tanker and dry-bulk rates surge alongside higher crude prices.

Priya Anand · 20 Sept 2026
Power Corporation highlights active ownership at Scotiabank summit
CompaniesArticle

Power Corporation highlights active ownership at Scotiabank summit

Power Corporation of Canada discusses its active ownership strategy and financial targets at the Scotiabank 27th Annual Financials Summit, with a focus on sustainable growth and AI investments.

Helena Vásquez · 20 Sept 2026
IFF says turnaround gains traction as leverage falls to 2.5x
CompaniesArticle

IFF says turnaround gains traction as leverage falls to 2.5x

CEO Erik Fyrwald highlighted progress on the three‑business model, a $3.8 bn Food Ingredients divestiture and a $2.5 bn share buyback while noting leverage has dropped to 2.5‑times.

Helena Vásquez · 20 Sept 2026
Aflac CFO Highlights 2026 Growth, AI and Japan Repositioning
CompaniesArticle

Aflac CFO Highlights 2026 Growth, AI and Japan Repositioning

Aflac’s CFO Max Brodén discussed capital allocation, operational efficiency gains from AI, and Japan’s evolving insurance market at KBW Insurance Conference 2026.

Helena Vásquez · 20 Sept 2026
Eco Buildings nears completion of first Albania apartment block
CompaniesArticle

Eco Buildings nears completion of first Albania apartment block

UK-listed construction firm hits key milestone on €13.2 million development with Balfin Group in Tirane, expects final contracts by year-end.

Helena Vásquez · 20 Sept 2026
AI Risk to Enter 60–80% of Insurance Underwriting by 2028, ScienceSoft Says
CompaniesArticle

AI Risk to Enter 60–80% of Insurance Underwriting by 2028, ScienceSoft Says

ScienceSoft projects AI risk considerations will become standard in E&O, D&O, employment practices and cyber insurance underwriting within two years.

Helena Vásquez · 20 Sept 2026
Culp swings to operating profit on restructuring gains in Q1 FY27
EarningsArticle

Culp swings to operating profit on restructuring gains in Q1 FY27

Culp Inc. reported a profitability reversal in its first fiscal 2027 quarter as restructuring saved roughly $22.5 million annually, pushing adjusted EBITDA positive and shares higher in after-hours trade.

Priya Anand · 20 Sept 2026
Articulate and Thinkific Partner on One-Click Content Integration
CompaniesArticle

Articulate and Thinkific Partner on One-Click Content Integration

Articulate and Thinkific Labs Inc. have launched a product integration that allows joint customers to publish training content between platforms with one click, eliminating manual exports, repackaging, and re-uploads.

Helena Vásquez · 20 Sept 2026
Specialised Therapeutics expands Incyte partnership to commercialize ruxolitinib cream in Australia
CompaniesArticle

Specialised Therapeutics expands Incyte partnership to commercialize ruxolitinib cream in Australia

Specialised Therapeutics, based in Singapore, will handle regulatory, medical, marketing and distribution duties for Incyte's ruxolitinib cream, Opzelura, across Australia.

Helena Vásquez · 20 Sept 2026